Almirall Seen Likely to Repeat Lung Drug Trial

MADRID, Oct 14 (Reuters) - Spanish pharmaceutical company Almirall is expected to announce on Wednesday that it will repeat clinical trials on its Aclidinium Bromide lung drug following a surprise setback last month, analysts said.